MedTech World Dubai – Abbott Launches Navitor Vision in India: Advancing Treatment for Aortic Stenosis

Abbott has introduced the Navitor Vision in India, a next-generation transcatheter aortic valve designed for patients with symptomatic severe aortic stenosis who face high or extreme surgical risks. This latest advancement in Abbott’s Navitor transcatheter aortic valve implantation (TAVI) system enhances visibility and precision during procedures, reinforcing the company’s commitment to innovative cardiovascular solutions.

Aortic stenosis, one of the most prevalent and life-threatening heart valve diseases, limits blood flow from the heart to the rest of the body. Left untreated, it can lead to heart failure and reduced life expectancy. In India, one in 40 people aged 75 and older experience this condition, making effective treatment options crucial. Historically, surgical aortic valve replacement was the standard approach, but not all patients could withstand open-heart surgery due to age, frailty, or other underlying health conditions.

Leggi l’articolo originale med-tech.world